Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0301 per EA under NDC 65162010210. Its NADAC has been published 626 times since Aug 27, 2014.
FDA first approved this application on Jul 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162010210
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA078428FDA Approved
7/25/2007
TE Code
AB
On Market Since
11/24/2009
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 626 times since Aug 27, 2014, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per EA |
|---|---|
| All-time high | $0.0601 (Jan 16, 2019) |
| All-time low | $0.0301 (Aug 19, 2026) |
| 52-week high | $0.0361 |
| 52-week low | $0.0301 |
| Median price | $0.0447 |
| Average price | $0.0451 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 626 |
| Tracking since | Aug 27, 2014 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Amneal Pharmaceuticals LLC, is $0.0301 per EA (NDC 65162010210), effective Aug 19, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 41.4%. It has been tracked across 626 weekly CMS publications since Aug 27, 2014.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Aug 27, 2014, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0301 (Aug 19, 2026) to a high of $0.0601 (Jan 16, 2019), with a median of $0.0447 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 65162010210) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.